<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>MBBS Pathology Notes: Hemolytic Anemia</title>
    <link href="https://fonts.googleapis.com/css2?family=Kalam:wght@300;400;700&display=swap" rel="stylesheet">
    <style>
        :root {
            --neon-yellow: #f4ff40; /* Neon yellowish highlighter */
            --marker-green: #daffb3; /* Natural light green marker */
            --ink-color: #2c2c2c; /* Dark grey/black ink look */
            --paper-white: #ffffff; /* Pure white page */
            --box-bg: #fffef0; /* Subtle warm tint for boxes */
            --border-color: #333;
        }

        * {
            box-sizing: border-box;
        }

        body {
            background-color: #525659; /* Grey background behind the paper */
            font-family: 'Kalam', cursive;
            color: var(--ink-color);
            margin: 0;
            padding: 20px;
            display: flex;
            justify-content: center;
            line-height: 1.6;
            font-size: 18px; /* Readable handwritten size */
        }

        /* A4 Paper Simulation */
        .page-container {
            background-color: var(--paper-white);
            width: 210mm; /* A4 width */
            min-height: 297mm; /* A4 height minimum */
            padding: 25mm; /* Standard margins */
            box-shadow: 0 4px 15px rgba(0,0,0,0.3);
            position: relative;
            margin-bottom: 20px;
        }

        /* Typography */
        h1 {
            font-size: 32px;
            text-align: center;
            text-decoration: underline;
            text-decoration-color: var(--neon-yellow);
            text-decoration-thickness: 5px;
            margin-bottom: 40px;
            color: #000;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        h2 {
            font-size: 26px;
            border-bottom: 3px solid var(--marker-green);
            padding-bottom: 5px;
            margin-top: 40px;
            color: #1a1a1a;
            display: inline-block;
            width: 100%;
        }

        h3 {
            font-size: 22px;
            font-weight: 700;
            margin-top: 25px;
            color: #333;
            text-decoration: underline;
        }

        h4 {
            font-size: 20px;
            font-weight: 700;
            margin-top: 15px;
            color: #444;
        }

        p {
            margin-bottom: 15px;
            text-align: justify;
        }

        ul, ol {
            margin-bottom: 15px;
            padding-left: 25px;
        }

        li {
            margin-bottom: 8px;
        }

        /* Highlighting Classes */
        .highlight-neon {
            background-color: var(--neon-yellow);
            padding: 2px 5px;
            border-radius: 4px;
            font-weight: bold;
        }

        .highlight-green {
            background-color: var(--marker-green);
            padding: 2px 5px;
            border-radius: 4px;
        }

        strong {
            font-weight: 700;
        }

        /* Hand-drawn Box Style */
        .hand-drawn-box {
            border: 2px solid var(--border-color);
            /* Irregular border radius for hand-drawn effect */
            border-radius: 2px 20px 3px 25px / 25px 3px 20px 2px;
            padding: 20px;
            margin: 25px 0;
            background-color: var(--box-bg); 
            box-shadow: 3px 4px 0px rgba(0,0,0,0.1);
        }

        /* Table Styling */
        table {
            width: 100%;
            border-collapse: separate;
            border-spacing: 0;
            margin: 20px 0;
            font-size: 16px;
            border: 2px solid var(--border-color);
            border-radius: 8px;
            overflow: hidden;
        }

        th, td {
            border-right: 1px solid var(--border-color);
            border-bottom: 1px solid var(--border-color);
            padding: 12px;
            text-align: left;
            vertical-align: top;
        }

        th {
            background-color: var(--marker-green);
            font-weight: bold;
            border-bottom: 2px solid var(--border-color);
        }

        tr:last-child td {
            border-bottom: none;
        }
        
        tr td:last-child, tr th:last-child {
            border-right: none;
        }

        /* Model Answer Section */
        .qa-section {
            border-left: 4px solid var(--neon-yellow);
            padding-left: 20px;
            margin-top: 30px;
        }

        /* Print Settings */
        @media print {
            body {
                background-color: white;
                padding: 0;
            }
            .page-container {
                width: 100%;
                box-shadow: none;
                margin: 0;
                padding: 15mm;
            }
            /* Ensure background colors print */
            * {
                -webkit-print-color-adjust: exact !important;
                print-color-adjust: exact !important;
            }
            h1, h2, h3 {
                page-break-after: avoid;
            }
            table, .hand-drawn-box, li {
                page-break-inside: avoid;
            }
        }

        /* Responsive Mobile */
        @media (max-width: 800px) {
            .page-container {
                width: 100%;
                padding: 15px;
            }
            table {
                font-size: 14px;
                display: block;
                overflow-x: auto;
            }
        }
    </style>
</head>
<body>

<div class="page-container">

    <h1>TOPIC 15: HEMOLYTIC ANEMIA</h1>

    <p><strong>Syllabus Scope:</strong> Definition, Classification, Pathogenesis, Lab Indices, Sickle Cell Anemia, Thalassemia, and Acquired Hemolytic Anemias.</p>

    <h2>1. DEFINITION AND CLASSIFICATION</h2>
    
    <p><strong>Definition:</strong> Hemolytic anemias are defined as anemias resulting from an increase in the rate of red blood cell (RBC) destruction, leading to a shortened RBC lifespan (normal: 120 days). The bone marrow compensates by increasing erythropoiesis (reticulocytosis).</p>

    <div class="hand-drawn-box">
        <h3>Classification of Hemolytic Anemias</h3>
        <p><strong>A. Hereditary (Intrinsic Defects)</strong></p>
        <ul>
            <li><strong>Membrane Defects:</strong> Hereditary Spherocytosis, Hereditary Elliptocytosis.</li>
            <li><strong>Enzyme Defects:</strong> G6PD Deficiency, Pyruvate Kinase Deficiency.</li>
            <li><strong>Hemoglobinopathies:</strong> Sickle Cell Anemia, Thalassemia.</li>
        </ul>
        <p><strong>B. Acquired (Extrinsic Defects)</strong></p>
        <ul>
            <li><strong>Immune-Mediated:</strong> Autoimmune Hemolytic Anemia (AIHA), Drug-induced.</li>
            <li><strong>Traumatic/Mechanical:</strong> Microangiopathic Hemolytic Anemia (DIC, TTP), Cardiac valve hemolysis.</li>
            <li><strong>Infections:</strong> Malaria.</li>
            <li><strong>Membrane Defect:</strong> Paroxysmal Nocturnal Hemoglobinuria (PNH) - <em>*Unique acquired intrinsic defect*</em>.</li>
        </ul>
    </div>

    <hr>

    <h2>2. GENERAL PATHOGENESIS AND CLINICAL FEATURES</h2>

    <h3>Pathogenesis</h3>
    <p>Hemolysis can occur in two sites:</p>
    <ol>
        <li><strong>Extravascular Hemolysis (Most common):</strong> Occurs within phagocytes of the spleen and liver. RBCs are less deformable or coated with antibodies (e.g., Spherocytosis, Sickle cell).
            <ul>
                <li><em>Consequence:</em> Jaundice, Splenomegaly.</li>
            </ul>
        </li>
        <li><strong>Intravascular Hemolysis:</strong> RBCs lyse within the blood vessels due to mechanical injury or complement fixation (e.g., Malaria, Transfusion reaction).
            <ul>
                <li><em>Consequence:</em> Hemoglobinemia, <span class="highlight-neon">Hemoglobinuria</span> (Red urine), Hemosiderinuria.</li>
            </ul>
        </li>
    </ol>

    <h3>Clinical Features</h3>
    <ul>
        <li>Pallor, Fatigue (Anemia).</li>
        <li><strong>Jaundice</strong> (Unconjugated hyperbilirubinemia).</li>
        <li><strong>Splenomegaly</strong> (Work hypertrophy of spleen).</li>
        <li>Pigment Gallstones (Bilirubin stones).</li>
        <li>Dark Urine (in intravascular hemolysis).</li>
    </ul>

    <h3>Hematologic Indices & Lab Findings</h3>
    <ul>
        <li><strong>Hemoglobin:</strong> Low.</li>
        <li><strong>Reticulocyte Count:</strong> <span class="highlight-green">Increased (> 2%)</span>. Indicates marrow response.</li>
        <li><strong>Bilirubin:</strong> Increased (Unconjugated/Indirect).</li>
        <li><strong>LDH (Lactate Dehydrogenase):</strong> Increased (released from lysed RBCs).</li>
        <li><strong>Haptoglobin:</strong> Decreased (binds free hemoglobin).</li>
        <li><strong>Urine:</strong> Urobilinogen increased. Hemoglobinuria (if intravascular).</li>
    </ul>

    <hr>

    <h2>3. SICKLE CELL ANEMIA (HbS)</h2>
    <p><strong>Definition:</strong> A hereditary hemoglobinopathy caused by a structural defect in the beta-globin chain.</p>

    <h3>Pathogenesis</h3>
    <ul>
        <li><strong>Mutation:</strong> Point mutation at position 6 of the &beta;-globin gene. <span class="highlight-neon">Valine substitutes Glutamic acid</span> (Glu &rarr; Val).</li>
        <li><strong>Mechanism:</strong>
            <ol>
                <li>Upon deoxygenation (hypoxia, acidosis, dehydration), HbS molecules polymerize into long needle-like fibers.</li>
                <li>This distorts the RBC into a <strong>Sickle shape</strong> (Drepanocyte).</li>
                <li>Sickling causes membrane damage (Ca<sup>2+</sup> influx) and makes RBCs sticky.</li>
            </ol>
        </li>
        <li><strong>Consequences:</strong>
            <ul>
                <li><strong>Vaso-Occlusion:</strong> Sickle cells block microvessels &rarr; Ischemia & Pain crises.</li>
                <li><strong>Hemolysis:</strong> Rigid cells are destroyed in the spleen (Extravascular).</li>
            </ul>
        </li>
    </ul>

    <h3>Clinical Features</h3>
    <ul>
        <li><strong>Vaso-occlusive Crises:</strong> Severe bone pain (Hand-Foot syndrome in infants), Chest syndrome, Stroke.</li>
        <li><strong>Autosplenectomy:</strong> Spleen initially enlarged, then fibrosed and shrunken due to repeated infarcts.</li>
        <li><strong>Aplastic Crisis:</strong> Parvovirus B19 infection causes temporary marrow shutdown.</li>
    </ul>

    <h3>Peripheral Blood Picture</h3>
    <ul>
        <li><strong>Sickle Cells (Drepanocytes):</strong> Crescent/boat-shaped cells.</li>
        <li><strong>Target Cells.</strong></li>
        <li><strong>Howell-Jolly Bodies:</strong> Nuclear remnants seen after autosplenectomy.</li>
        <li><strong>Polychromasia:</strong> Reticulocytes.</li>
    </ul>

    <hr>

    <h2>4. THALASSEMIA</h2>
    <p><strong>Definition:</strong> A group of inherited disorders caused by reduced or absent synthesis of one or more globin chains (&alpha; or &beta;).</p>

    <h3>Pathogenesis (Beta-Thalassemia Major)</h3>
    <ul>
        <li><strong>Defect:</strong> Mutation in &beta;-globin gene &rarr; Absent (&beta;<sup>0</sup>) or reduced (&beta;<sup>+</sup>) &beta;-chains.</li>
        <li><strong>Imbalance:</strong> Excess unsubstituted &alpha;-chains precipitate within RBC precursors.</li>
        <li><strong>Consequences:</strong>
            <ul>
                <li><strong>Ineffective Erythropoiesis:</strong> Marrow precursors die before release (Apoptosis).</li>
                <li><strong>Hemolysis:</strong> Released RBCs are destroyed by the spleen.</li>
                <li><strong>Iron Overload:</strong> Due to repeated transfusions and increased absorption.</li>
            </ul>
        </li>
    </ul>

    <h3>Clinical Features</h3>
    <ul>
        <li>Severe anemia starting at 6-9 months (after HbF declines).</li>
        <li><strong>Skeletal Deformities:</strong> "Chipmunk facies", "Hair-on-end" appearance on X-ray (Marrow expansion).</li>
        <li>Hepatosplenomegaly.</li>
    </ul>

    <h3>Peripheral Blood Picture</h3>
    <ul>
        <li><strong>Microcytic Hypochromic Anemia</strong> (MCV < 70 fL).</li>
        <li><strong>Target Cells (Codocytes):</strong> Prominent.</li>
        <li><strong>Basophilic Stippling:</strong> Aggregated ribosomes.</li>
        <li><strong>Nucleated RBCs:</strong> Normoblasts seen in peripheral blood (Marrow stress).</li>
    </ul>

    <hr>

    <h2>5. ACQUIRED HEMOLYTIC ANEMIA</h2>

    <h3>A. Autoimmune Hemolytic Anemia (AIHA)</h3>
    <p>Caused by antibodies against own RBCs. Diagnosed by <span class="highlight-green">Coombs Test (DAT)</span>.</p>
    <ul>
        <li><strong>Warm Antibody Type (IgG):</strong> Active at 37°C. Spleen destroys IgG-coated RBCs.
            <br><em>Etiology:</em> SLE, Lymphoma, Drugs (Methyldopa).
            <br><em>Smear:</em> <strong>Microspherocytes</strong> (Spleen bites off membrane).</li>
        <li><strong>Cold Antibody Type (IgM):</strong> Active at 4°C. IgM fixes complement.
            <br><em>Etiology:</em> Mycoplasma pneumonia, Mononucleosis.
            <br><em>Smear:</em> <strong>RBC Agglutination</strong> (Clumping).</li>
    </ul>

    <h3>B. Microangiopathic Hemolytic Anemia (MAHA)</h3>
    <p>Mechanical fragmentation of RBCs as they pass through fibrin strands in blocked vessels.</p>
    <ul>
        <li><em>Etiology:</em> DIC, TTP, HUS, Malignant Hypertension.</li>
        <li><em>Smear:</em> <strong>Schistocytes</strong> (Helmet cells, fragmented RBCs).</li>
    </ul>

    <hr>

    <h2>6. PERIPHERAL BLOOD PICTURE SUMMARY</h2>

    <table>
        <thead>
            <tr>
                <th>Condition</th>
                <th>Characteristic RBC Shape/Finding</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td><strong>Hereditary Spherocytosis</strong></td>
                <td>Spherocytes (Small, dark, no central pallor).</td>
            </tr>
            <tr>
                <td><strong>Sickle Cell Anemia</strong></td>
                <td>Sickle cells, Howell-Jolly bodies.</td>
            </tr>
            <tr>
                <td><strong>Thalassemia</strong></td>
                <td>Target cells, Nucleated RBCs, Basophilic Stippling.</td>
            </tr>
            <tr>
                <td><strong>G6PD Deficiency</strong></td>
                <td>Bite cells, Blister cells (Heinz bodies).</td>
            </tr>
            <tr>
                <td><strong>Microangiopathic (DIC/TTP)</strong></td>
                <td>Schistocytes (Helmet cells).</td>
            </tr>
            <tr>
                <td><strong>Autoimmune (Warm)</strong></td>
                <td>Microspherocytes, Polychromasia.</td>
            </tr>
            <tr>
                <td><strong>Autoimmune (Cold)</strong></td>
                <td>RBC Agglutination.</td>
            </tr>
        </tbody>
    </table>

    <hr>

    <h2>7. PREPARATION OF PERIPHERAL SMEAR</h2>
    <p>To identify hemolytic anemia, a well-made smear is essential.</p>
    
    <div class="hand-drawn-box">
        <h3>Steps (Wedge Technique)</h3>
        <ol>
            <li><strong>Sample:</strong> Use EDTA venous blood or fresh finger prick.</li>
            <li><strong>Drop:</strong> Place a small drop of blood 1 cm from the end of a clean glass slide.</li>
            <li><strong>Spreader:</strong> Place a smooth-edged "spreader" slide at a <strong>30-45° angle</strong> in front of the drop.</li>
            <li><strong>Spread:</strong> Pull back to touch the drop (let it spread along width), then push forward rapidly and smoothly.</li>
            <li><strong>Dry & Stain:</strong> Air dry. Fix with Methanol. Stain with <strong>Leishman</strong> or Giemsa.</li>
            <li><strong>Examine:</strong> Look at the <strong>Tail (Feathered edge)</strong> where cells are separated. Look for Polychromasia (blue-grey young RBCs) and specific shapes (Spherocytes, Sickle cells).</li>
        </ol>
    </div>

    <hr>

    <h2 style="color: #d32f2f; border-color: #d32f2f;">IMPORTANT UNIVERSITY QUESTIONS</h2>

    <div class="qa-section">
        <h3>Q1: Classify Hemolytic Anemias. Describe the pathogenesis and lab diagnosis of Sickle Cell Anemia.</h3>
        <p><strong>Introduction:</strong> Hemolytic anemias are characterized by reduced RBC lifespan. They are classified into Intracorpuscular (Hereditary) and Extracorpuscular (Acquired) defects.</p>
        <p><strong>Body:</strong>
            <br><strong>Pathogenesis of SCA:</strong> It is caused by a point mutation (Glu &rarr; Val) in the &beta;-globin chain. Deoxygenation causes HbS to polymerize, distorting RBCs into rigid sickles. These obstruct vessels (Vaso-occlusive crisis) and are destroyed in the spleen (Hemolysis).
            <br><strong>Lab Diagnosis:</strong>
            <ul>
                <li><em>CBC:</em> Low Hb, High Retic count.</li>
                <li><em>Smear:</em> Sickle cells, Target cells, Howell-Jolly bodies.</li>
                <li><em>Sickling Test:</em> Sodium metabisulfite induces sickling.</li>
                <li><em>Electrophoresis:</em> HbS band present (Definitive).</li>
            </ul>
        </p>
        <p><strong>Conclusion:</strong> SCA is a severe hemolytic disorder with multisystem ischemic complications.</p>
    </div>

    <div class="qa-section">
        <h3>Q2: Discuss the Peripheral Blood findings in Thalassemia and Autoimmune Hemolytic Anemia.</h3>
        <p><strong>Introduction:</strong> Peripheral smear examination is a rapid diagnostic tool for distinguishing hemolytic anemias.</p>
        <p><strong>Body:</strong>
            <br><strong>1. Thalassemia Major:</strong> The smear shows severe microcytic hypochromic anemia. Key features are <strong>Target cells</strong>, <strong>Nucleated RBCs</strong> (erythroblastemia due to marrow stress), and <strong>Basophilic Stippling</strong>. Anisopoikilocytosis is marked.
            <br><strong>2. Autoimmune Hemolytic Anemia (Warm Type):</strong> The hallmark finding is the <strong>Spherocyte</strong> (small, hyperchromic RBC without central pallor), formed when splenic macrophages remove antibody-coated membrane. Polychromasia (Reticulocytes) is prominent. Cold type shows <strong>Agglutination</strong>.</p>
        <p><strong>Conclusion:</strong> Spherocytes suggest immune hemolysis (Coombs positive), while Target cells suggest hemoglobinopathy.</p>
    </div>

</div>

</body>
</html>